PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Pediatr. Author manuscript; available in PMC Apr 1, 2010.
Published in final edited form as:
PMCID: PMC2693887
NIHMSID: NIHMS106672
Positive Screening on the Modified-Checklist for Autism in Toddlers (M-CHAT) in Extremely Low Gestational Age Newborns
Karl C. K. Kuban, M.D., S.M. Epi.,1 T. Michael O’Shea, M.D., M.P.H,2 Elizabeth N. Allred, M.S.,3,4 Helen Tager-Flusberg,5 Donald J. Goldstein,2 and Alan Leviton, M.D.3, All authors are members of the ELGAN Study Group.
1 Div. of Pediatric Neurology, Dept. of Pediatrics, Boston Medical Center, Boston University, Boston, MA
2 Dept. of Pediatrics, Wake Forest University, Winston-Salem, NC
3 Neuroepidemiology Unit, Dept. of Neurology, Children’s Hospital Boston, Harvard University, Boston, MA
4 Dept. of Biostatistics, Harvard School of Public Health, Harvard University, Boston, MA
5 Department of Anatomy and Neurobiology & Pediatrics, Boston University School of Medicine, Boston, MA
Corresponding author: Karl Kuban, MD, SMEpi, One Boston Medical Center Place, Dowling 3 South, Boston, MA 02118, karl.kuban/at/bmc.org, 617-414-4548
Objective
To test the hypothesis that children born preterm are more likely to screen positive on the M-CHAT for an autism spectrum disorder.
Study design
We explored the possibility that motor, vision, hearing and cognitive impairments might contribute to this increase.
Results
Relative to children who could walk, the odds for screening positive on the M-CHAT was increased 23-fold for those unable to sit or stand independently and more than 7-fold for those needing assistance to walk. Compared with children without a CP diagnosis, those with quadriparesis were 13 times more likely and those with hemiparesis were 4 times more likely to screen positive. Children with major vision or hearing impairments were 8 times more likely to screen positive than those without such impairments. Relative to those with an MDI greater than 70, the odds for screening positive were increased 13-fold for those with an MDI below 55 and more than 4-fold for those with an MDI 55–69.
Conclusion
Major motor, cognitive, visual, and hearing impairments appear to account for more than half of the positive M-CHAT screens among extremely low gestational age newborns. Even after eliminating those with such impairments, 10% of children, or nearly double the expected rate, screened positive.
Keywords: Cerebral palsy, Neurodevelopmental outcomes
The Council on Children with Disabilities of the American Academy of Pediatrics recommends that pediatricians screen for an autism spectrum disorder (ASD) if there are concerns about the child’s development [1]. One of the “ASD-specific screening tools” is the M-CHAT [2]. When the M-CHAT is used as a screen in unselected children during well-child care visits between 16 and 30 months of age, 5.7% screen positive [3]. In contrast, we have found that 21% of infants born before the 28th week of gestation screen positive for ASD on the M-CHAT [4]. Four studies found that children born preterm are at greater risk of an autism diagnosis than children born at term [5,[ 6],[7, 8], and two other studies found that low birth weight was associated with increased risk of an autism diagnosis [9], [10]. One recent study reported an elevated rate of screening positive on the M-CHAT in a selected low birth weight cohort [11].
Two compatible explanations for this apparently very high rate seem plausible. One is that extremely low gestational age newborns (ELGANs) are at increased risk for autism spectrum disorders. The other is that developmental impairments other than ASD (for which ELGANs are at increased risk) [4, 1214] increase the frequency of screening positive. For example, the parent of a child with severe motor impairment might mark as abnormal such items on the M-CHAT screen as, “Does not point to indicate interest” or “Does not bring objects to you”, two of the M-CHAT critical items, even though the child may show no language or social impairment. We evaluated to what extent developmental impairments contribute to the risk of screening positive on the M-CHAT.
The ELGAN Study
The ELGAN study was designed to identify characteristics and exposures that increase the risk of structural and functional neurologic disorders in ELGANs (the acronym for Extremely Low Gestational Age Newborns). During the years 2002–2004, women delivering before 28 weeks gestation at one of 14 participating institutions in 11 cities in 5 states were asked to enroll in the study. The enrollment and consent processes were approved by the individual institutional review boards.
Mothers were approached for consent either upon antenatal admission or shortly after delivery, depending on clinical circumstance and institutional preference. 1249 mothers of 1506 infants consented. 257 women were either missed or did not consent to participate.
24-month developmental assessment
Seventy-seven percent had developmental assessments within the range of 23.5–27.9 months; of the others, about half were assessed before 23.5 months and about half after 27.9 months. Of the 1200 children who survived to 24-months corrected age, 988 had a complete developmental assessment that included a neurological examination, the Gross Motor Functional Classification System (GMFCS), the Bayley Scales of Infant Development, Second edition (BSID-II), and several parent reported assessments, including the Modified-Checklist for Autism in Toddlers (M-CHAT) (Figure). The parent or other caregiver who brought the child for the 24 month developmental assessment was also interviewed in order to complete a standardized 60-item interval medical history form. One of the questions asked if the child had a hearing problem, and, if so, whether the child required a hearing aid or needed special services for hearing impairment. The parent or other caregiver was also asked if the child had a vision problem and if the child was considered to be legally blind.
Modified Checklist for Autism in Toddlers
The M-CHAT asks the parent or other caregiver to report on 23 behaviors. A child screened positive if 2 of 6 “critical” items (Items 2, 7, 9, 13, 14, 15) or three of any of the 23 total items were abnormal (Table I). Of the 23 items, six required a reasonably intact motor system (Items 3, 6, 7, 9, 13, 16), thirteen required visual competence (items 2, 4, 5, 6, 7, 8, 10, 12, 13, 15, 17, 22, 23), and four required intact hearing (items 11, 14, 21, 20).
Table 1
Table 1
The percent of children who screened positive and negative on the M-CHAT and were marked as abnormal on the items listed on the left. The items are ordered in 4 sets that group them functionally and items that require multiple capabilities are listed (more ...)
Cerebral palsy
Those who performed the neurological examinations studied a manual, a data collection form and an instructional CD designed to minimize examiner variability, and demonstrated acceptably low variability [15]. The topographic diagnosis of cerebral palsy (CP) (quadriparesis, diparesis, or hemiparesis) was based on an algorithm [4]. The individual performing the neurologic examination also completed the GMFCS form assigning each child in the cohort to a level of gross motor function.
Bayley Scales of Infant Development – Second Edition (BSID-II) [16]
Certified examiners administered and scored the BSID-II [12] All examiners had prior experience with the BSID-II and attended a one-day workshop at which the published guidelines for test administration and videotaped examinations were viewed and discussed. Examiners were aware of the infant’s enrollment in the ELGAN Study but were not informed of any specifics of the child’s medical history. Before testing, examiners were told the child’s corrected age; after completion of testing they were told the child’s birth date so that the unadjusted BSID-II Mental Development Index (MDI) and Psychomotor Development index (PDI) scores could be obtained.
When a child’s impairments precluded administration of the BSID-II, or more than 2 items were omitted or judged to be ‘unscoreable,’ the child was classified as non-testable on that scale. The Adaptive Behavioral Composite (ABC) of the Vineland Adaptive Behavior Scales (VABS) was obtained for 26 of 33 children who were considered non-testable with the BSID-II Mental Scale. Of the 38 infants unscoreable with the BSID-II Psychomotor Scale, 32 were assessed with the VABS Motor Skills Domain. These children’s scores on the ABC and the VABS served as the basis for imputation of the BSID-II scores.
Data analysis
Among the candidate prematurity-associated dysfunctions that might account for the high rate of positive screens are those associated with motor, vision, hearing and cognitive impairments. We compared the rate of motor, vision, hearing and cognitive impairments among children screened positive on the M-CHAT with the rate among those who screened negative. We also evaluated the frequency with which items from the M-CHAT requiring intact motor, vision, and hearing were reported as abnormal in those who had motor handicap, vision difficulties, hearing limitations, and cognitive dysfunctions (by MDI).
Motor, vision, hearing and cognitive limitations tend to cluster in this sample. For example, children with quadriparesis were more than three times as likely to have an MDI below 70 as those without CP [4]. Thus, models for screening positive on the M-CHAT that include variables for motor, vision, hearing and cognitive limitations are unlikely to truly reflect the contributions of each set of limitations. With that caveat, we created a multivariate logistic regression model that retained one indicator for each of these limitations.
More than 21% (212/988) of all children screened positive for ASD on the M-CHAT (Table I). Among children without motor, vision, hearing or cognitive impairment, 10% screened positive (Table II). Because two-thirds of children with an ASD are also cognitively impaired [5], excluding children from the referent group on the basis of cognitive limitations eliminates some who are at high risk of an ASD. Consequently, we created a second referent group that excludes children with motor, vision and hearing impairments, but includes children with the full range of MDI scores (Table II). Sixteen percent of children in this referent group still screened positive on the M-CHAT.
Table 2
Table 2
The percent of children with the clinical characteristics identified on the left who screened positive on the M-CHAT
Association of positive M-CHAT with motor impairment
The more severe the motor limitation as assessed with the GMFCS, the more likely the child screened positive on the M-CHAT (Table II). For example, the rate was lowest in those who could walk (GMFCS <1: 17%), intermediate in those who needed assistance to walk (GMFCS = 1: 60%), and highest in those who could not sit or walk even with assistance (GMFCS ≥2: 83%). Similarly, even though 17% of children not given a cerebral palsy (CP) diagnosis screened positive, those who had CP had rates that were considerably higher (diparesis: 29%; hemiparesis: 44%; quadriparesis: 73%). The lower the PDI, another indicator of motor ability, the higher the probability the child screened positive on the M-CHAT (PDI < 55: 57%; 56–69: 28%; ≥ 70: 12%).
We calculated point estimates of odds ratios of screening positive and their 95% confidence intervals for each of the individual impairments. Relative to children who could walk (GMFCS <1), the odds for screening positive was increased 23-fold for those who could not sit or stand independently (GMFCS ≥ 2) and more than 7-fold for those who needed assistance to walk (GMFCS = 1) (Table III). Compared with children who were not given a CP diagnosis, those with quadriparesis were 13 times more likely and those with a hemiparesis were almost 4 times more likely to screen positive for ASD on the M-CHAT. The doubling of risk among diparetic infants was not statistically significant.
Table 3
Table 3
Odds ratios (and their 95% confidence intervals) for screening positive on the M-CHAT by the impairments listed in the left column. The referent group for each impairment is the unidentified group (GMFCS < 1, No CP, PDI ≥ 70, normal vision, (more ...)
Considering items that require relatively intact motor abilities, the median number of M-CHAT items marked abnormal was 5 for children with GMFCS of 2 or higher, 2 for those with GMFCS of 1, and 0 for those with minimal or no motor impairment (data not shown).
Association of positive M-CHAT with a history of neurosensory impairment
Of the 25 children deemed legally blind in at least one eye, 68% were M-CHAT positive, whereas 20% of their peers were M-CHAT positive (Table II). Of the 19 children who required a hearing aid or received specialized services for the hearing impaired, 68% were M-CHAT positive. In contrast, 21% of their peers were M-CHAT positive. Compared with children without their impairment, children considered blind and children with a hearing impairment had an odds ratio for screening positive of 8.4 (Table III).
Considering items that require relatively intact visual abilities, the median number of M-CHAT items marked abnormal, was 5 for those who were visually impaired and 0 for those who were not (data not shown). Considering items that require relatively intact hearing, the mean number of items marked abnormal, was 1 for those who were hearing impaired and 0 for those who were not.
Association of positive M-CHAT with neurocognitive impairment
The more severe the cognitive limitation, the more likely the child screened positive on the M-CHAT. For example, 61% of children whose MDI was less than 55 screened positive, compared with 35% of children whose MDI was between 55 and 69, and 11% of children whose MDI was 70 or higher (Table II).
The M-CHAT was designed for screening of children between 18–30 months of age and has not been validated in children under 16 months of age [2], [3]. We re-evaluated the association of M-CHAT positivity with Bayley Scales separately for those whose adjusted MDI equivalent was over and under 16 months. Half of the 220 children with mental age less than 16 months screened positive on the M-CHAT in comparison to 13% of children with mental age above 16 months.
Relative to those who had an MDI of 70 or more, the odds for screening positive was increased 13-fold for those with an MDI below 55 and more than 4-fold for those with an MDI 55-69 (Table III). Excluding children who had a GMFCS of 1 or more, the odds for screening positive was still more than 6-fold for those with an MDI less than 55 and nearly 4-fold for an MDI of 56–69.
Multivariate models
We created a logistic regression model that simultaneously evaluated the contribution of multiple impairments, each in light of the other, to the risk of a positive M-CHAT. Motor impairment had the strongest association; but cognitive, visual, and hearing impairments were also important (Table III).
Among children who were born at an extremely low gestational age, those who have motor, vision, or hearing impairments are much more likely than others to screen positive on the M-CHAT. Because we have yet to assess these children for an autism-spectrum disorder at an older age, we do not know if these children with motor, vision, or hearing impairments really are at increased risk of an autism-spectrum disorder, or if their visual, hearing, and motor deficits are equated with characteristics commonly seen in autism, such as visual avoidance, inconsistent response to voice, and failure to point or play with toys.
Although some of the risk of screening positive on the M-CHAT appears to be related to motor and special sensory impairments, among children without such impairments, the rate of screening positive was still 16%, nearly three times higher than expected among unselected populations. Even among children without cognitive impairment, 10% screened positive, nearly twice the rate expected.
The M-CHAT was developed in the late 1990s as a first-stage screen for ASD in toddlers aged 18 to 24 months with sensitivity of 0.87 and specificity of 0.99 in American children [2], [17]. More recent reports indicate that sensitivity, specificity, and positive predictive value (PPV) might be lower [3, 18]. In unselected children, the PPV is 0.11, and in high-risk children it is 0.6 [3]. When adding telephone interview confirmation for the M-CHAT screens, something that was not done in the ELGAN study, PPV increases to 0.65 in unselected children and to 0.76 in high-risk children. If the M-CHAT were an ideal screening tool, it would identify all who should be given an autism-spectrum diagnosis (high sensitivity), and a low number of others who should not be given this diagnosis (high specificity). Only 0.6% of children in the general population are given an autism-spectrum diagnosis [19, 20], yet almost ten times that many (5.7%) screen positive [3]. In contrast, however, 21% of our sample screened positive.. We have not yet verified ASD in our sample, and so cannot provide any information about sensitivity, specificity and predictive values of the MCHAT in our sample.
Children whose mental age was below 16 months equivalent were much more likely to be M-CHAT positive than the remainder of the cohort. Inclusion of children with mental age less than 16 months should not diminish the importance of our findings because two-thirds of children destined to have ASD have cognitive impairment [21].
Approximately 70% of children with autism have no identifiable medical or genetic cause and are morphologically normal [22]. Among such children with “idiopathic” autism, the ratio of boys to girls is close to 4 rather than the ratio of between 1 and 2 seen among children who have a medical or genetic cause or are morphologically abnormal. Fully 15% of children with idiopathic autism have macrocephaly, whereas microcephaly appears to be especially common among the children who have a syndrome or a medical- genetic basis for their ASD [22]. Finally, severe cognitive impairment is considerably more common among children with syndromic and otherwise explained autism than among children with idiopathic autism [22]. With a sex ratio of 1.4, an elevated rate of microcephaly (data not shown), and a high rate of severe cognitive impairment, the children who screened positive in our sample more closely resemble the pattern seen in children who have syndromic/medical-genetic disorder-explained autism than in those with idiopathic autism.
If an appreciable proportion of the children in our sample are documented to have ASD, some of the increased rate might be attributable to prematurity-related antecedents. One study found that among adolescents with normal IQ and vision, those diagnosed with periventricular leukomalacia were more likely than controls to have impairments in perceiving and understanding the actions of others, features seen also in those with ASD [23]. These children had diminished right temporal lobe white matter size on MRI volumetric studies.
We raise the possibility that in its present form, the specificity of the M-CHAT may be low among children born extremely prematurely because of associated developmental impairments and other unrecognized characteristics Because this cohort did not undergo a diagnostic evaluation for autism, we cannot assess the false positive rate for the M-CHAT screen. If the verified rate of ASD in our population is only minimally or moderately increased among children who screen positive, however, then the M-CHAT might require modification for use in children born at extremely low gestational ages and for children who have physical and special sensory impairments.
Our cohort is at high risk for developmental impairments, whether or not they ultimately carry the diagnosis of ASD, because 23% of children with a false positive M-CHAT have developmental language disabilities and/or global developmental disorders [18]. Indeed, our data indicate that only 10% of ELGAN children who screen positive on the M-CHAT have a normal MDI and PDI.
Strengths of the current study include the large sample based on gestational age rather than birth weight, efforts to minimize inter-observer disagreements about motor findings, standardized administration of the BSID-II, and completion of the M-CHAT screen. A limitation of the M-CHAT screen in this study is that telephone confirmation of results was not sought.
Figure 1
Figure 1
Sample description.
Acknowledgments
We thank Elizabeth Caronna, MD, for her reading of the manuscript and her sage advice. The following centers participated in the ELGAN Study: Baystate Medial Center, Springfield, MA, Beth Israel Deaconess Medical Center, Boston, MA, Brigham & Women’s Hospital, Boston, MA Massachusetts General Hospital, Boston, MA, New England Medical Center, Boston, MA, Children’s Hospital, Boston, Boston Medical Center, Boston, MA, Boston, MA, University of Massachusetts Memorial Health Center, Worcester, MA, Yale-New Haven Hospital, New Haven, CT, Forsyth Hospital, Baptist Medical Center, Winston-Salem, NC, University Health Systems of East Carolina, Greenville, NC, North Carolina Children’s Hospital, Chapel Hill, NC, DeVos Children’s Hospital, Grand Rapids, MI, Sparrow Hospital, Lansing MI, Michigan State University, E. Lansing, MI, University of Chicago Hospital, Chicago, IL, William Beaumont Hospital, Royal Oak, MI
Financial support for this research was provided by the National Institute of Neurological Disorders and Stroke (cooperative agreement 1 U01 NS 40069-01A2). The authors declare no conflicts of interest.
Footnotes
Edited by AJ and WFB
Acknowledgment available at www.jpeds.com.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
1. Johnson FW. Biological factors and psychometric intelligence: a review. Genet Soc Gen Psychol Monogr. 1991;117(3):313–57. [PubMed]
2. Robins D, Fein D, Barton M, Green J. The Modified Checklist for Autism in Toddlers: An initial study investigating the early detection of autism and pervasive developmental disorders. Journal of Autism and Developmental Disorders. 2001;31:131–151. [PubMed]
3. Kleinman JM, Robins DL, Ventola PE, Pandey J, Boorstein HC, Esser EL, et al. The Modified Checklist for Autism in Toddlers: A Follow-up Study Investigating the Early Detection of Autism Spectrum Disorders. J Autism Dev Disord. 2007 [PMC free article] [PubMed]
4. Kuban K, Allred Elizabeth N, O’Shea TM, Paneth N, Pagano M, Dammann O, Marshall D, Soul JS, Engelke S, O’Connor SE, Gilmore H, Duplessis A, Krishnamoorthy K, Hahn C, Miller K, Church PT, Keller C, Bream R, Adair R, Miller AR, Omano E, Bassan H, Milowic K, Hubbard C, Washburn L, Dillard R, Heller C, Burdo-Hartman W, Fagerman L, Sutton D, Karna P, Olomu N, Caldarelli L, Oca M, Lohr K, Scheiner A, Khwaha O, Stine C, SacGilvray SS, Buckwald S, Caine V, Leviton A. An algorithm for identifying and classifying cerebral palsy in young children. Journal of Pediatrics. 2008 In Press.
5. Larsson HJ, Eaton WW, Madsen KM, Vestergaard M, Olesen AV, Agerbo E, et al. Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. American Journal of Epidemiology. 2005;161(10):916–25. discussion 926–8. [PubMed]
6. Schendel D, Bhasin TK. Birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Pediatrics. 2008;121(6):1155–64. [PubMed]
7. Halsey CL, Collin MF, Anderson CL. Extremely low-birth-weight children and their peers. A comparison of school-age outcomes. Archives of Pediatrics & Adolescent Medicine. 1996;150(8):790–4. [PubMed]
8. Indredavik MS, Vik T, Heyerdahl S, Kulseng S, Fayers P, Brubakk AM. Psychiatric symptoms and disorders in adolescents with low birth weight. Archives of Disease in Childhood Fetal & Neonatal Edition. 2004;89(5):F445–50. [PMC free article] [PubMed]
9. Eaton WWMP, Thomsen PH, Frydenberg M. Obstetric complications and risk for severe psychopathology in childhood. J Autism Dev Disord. 2001;31:279 –285. [PubMed]
10. Burd L, Severud R, Kerbeshian J, Klug MG. Prenatal and perinatal risk factors for autism. J Perinat Med. 1999;27(6):441–50. [PubMed]
11. Limperopoulos C, Bassan H, Sullivan NR, Soul JS, Robertson RL, Jr, Moore M, et al. Positive screening for autism in ex-preterm infants: prevalence and risk factors. Pediatrics. 2008;121(4):758–65. [PMC free article] [PubMed]
12. Rice SA, Bigler ED, Cleavinger HB, Tate DF, Sayer J, McMahon W, et al. Macrocephaly, corpus callosum morphology, and autism. Journal of Child Neurology. 2005;20(1):34–41. [PubMed]
13. Aylward EH, Minshew NJ, Field K, Sparks BF, Singh N. Effects of age on brain volume and head circumference in autism. Neurology. 2002;59(2):175–83. [PubMed]
14. Herbert MR, Ziegler DA, Deutsch CK, O’Brien LM, Lange N, Bakardjiev A, et al. Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain. 2003;126(Pt 5):1182–92. [PubMed]
15. Kuban K, O’Shea M, Allred E, Leviton A, Gilmore H, DuPlessis A, et al. Video and CD-ROM as a Training Tool for Performing Neurologic Examinations of 1-Year-Old Children in a Multicenter Epidemiologic Study. Journal of Child Neurology. 2005;20(10):829–831. [PubMed]
16. Bayley N. Bayley Scales of Infant Development. 2. Psychological Corporation; 1993.
17. Pinto-Martin J, Levy S. Early Diagnosis of Autism Spectrum Disorders. Current Treatment Options in Neurology. 2004;6(5):391–400. [PubMed]
18. Ventola P, Kleinman J, Pandey J, Wilson L, Esser E, Boorstein H, et al. Differentiating between autism spectrum disorders and other developmental disabilities in children who failed a screening instrument for ASD. J Autism Dev Disord. 2007;37(3):425–36. [PubMed]
19. Chakrabati S, Fombonne E. Pervasive Developmetal Disorders in Preschool Children: Confirmation of high prevalence. American Journal of Psychiatry. 2005;162l:1133–1141. [PubMed]
20. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of autism in a US metropolitan area. JAMA. 2003;289(1):49–55. [PubMed]
21. Tuchman R, Rapin I. Epilepsy in autism. Lancet Neurology. 2002;1(6):352–8. [PubMed]
22. Miles JH, Hillman RE. Value of a clinical morphology examination in autism. American Journal of Medical Genetics. 2000;91(4):245–53. [PubMed]
23. Pavlova M, Sokilov AN, Birbaumer N, Krageloh-Mann I. Perception and Understanding of Others’ Actions and Brain Connectivity. J of Cognitive euroscience. 2008;20:494–504. [PubMed]